Detalles de la búsqueda
1.
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial.
Gut
; 63(6): 919-27, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23878167
2.
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
NEJM Evid
; 1(8): EVIDoa2200061, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319804
3.
Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.
Scand J Gastroenterol
; 46(3): 310-8, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21087119
4.
Maintenance therapy with certolizumab pegol for Crohn's disease.
N Engl J Med
; 357(3): 239-50, 2007 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-17634459
5.
Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies.
Scand J Gastroenterol
; 44(7): 774-81, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19140087
6.
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
Inflamm Bowel Dis
; 13(4): 481-9, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17206705
7.
World Gastroenterology Organisation global guideline: Constipation--a global perspective.
J Clin Gastroenterol
; 45(6): 483-7, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21666546
8.
Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Dan Med J
; 62(1): B4995, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25557336
9.
Immunosuppressive drugs impairs antibody response of the polysaccharide and conjugated pneumococcal vaccines in patients with Crohn's disease.
Vaccine
; 33(41): 5464-5469, 2015 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275480
10.
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.
Inflamm Bowel Dis
; 20(10): 1714-21, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25069030
11.
Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial.
BMJ Open
; 4(12): e005887, 2014 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25524543
12.
Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease.
J Crohns Colitis
; 6(1): 108-11, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22261535
13.
[Mesalamine in the treatment of Crohn disease?]. / Slangeolie til behandling af Crohns sygdom?
Ugeskr Laeger
; 167(15): 1656-7, 2005 Apr 11.
Artículo
en Da
| MEDLINE | ID: mdl-15892345
14.
[Monitoring of bioavailability, pharmacokinetics and immunogenicity of tumour necrosis factor-alpha inhibitors]. / Monitorering af tumornekrosefaktor alfa-haemmeres biotilgaengelighed, farmakokinetik og immunogenicitet.
Ugeskr Laeger
; 172(1): 44-7, 2010 Jan 04.
Artículo
en Da
| MEDLINE | ID: mdl-20056095
15.
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
Med Decis Making
; 30(1): 132-42, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19605883
16.
Diagnosis and management of fistulizing Crohn's disease.
Nat Clin Pract Gastroenterol Hepatol
; 6(2): 92-106, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19153563
17.
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
Scand J Gastroenterol
; 42(2): 221-7, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17327942
18.
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease.
Gastroenterology
; 129(3): 807-18, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16143120
19.
[5-aminosalicylic acid and cancer prophylaxis?]. / 5-aminosalicylsyre og kraerftprofylakse?
Ugeskr Laeger
; 168(21): 2047, 2006 May 22.
Artículo
en Da
| MEDLINE | ID: mdl-16768920
20.
[Mesalazine for maintenance of medically-induced remission in Crohn disease: a survey of a Cochrane review]. / Mesalazin til vedligeholdelse af medikamentelt induceret remission i Crohns sygdom: gennemgang af et Cochrane-review.
Ugeskr Laeger
; 167(33): 3015-7, 2005 Aug 15.
Artículo
en Da
| MEDLINE | ID: mdl-16109240
Resultados
1 -
20
de 20
1
Próxima >
>>